https://sputnikglobe.com/20211029/us-approves-emergency-use-of-pfizer-covid-19-vaccine-for-children-5-11-years-old-1090326739.html
US Approves Emergency Use of Pfizer COVID-19 Vaccine for Children 5-11 Years Old
US Approves Emergency Use of Pfizer COVID-19 Vaccine for Children 5-11 Years Old
Sputnik International
WASHINGTON (Sputnik) - The US Food and Drug Administration (FDA) said on Friday it approved the emergency use of the Pfizer coronavirus vaccine in children... 29.10.2021, Sputnik International
2021-10-29T19:45+0000
2021-10-29T19:45+0000
2021-10-29T19:46+0000
us
vaccination
pfizer
vaccine
food and drug administration (fda)
covid-19
delta variant of covid-19
https://cdn1.img.sputnikglobe.com/img/07e5/0a/1d/1090326714_0:38:946:570_1920x0_80_0_0_73f88c0319c46f7eff99c15c9b5acda8.jpg
"Today, the US Food and Drug Administration authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age," the FDA said in a press release.Last Saturday, FDA released a report in which it indicated that the predicted benefits from the Pfizer COVID-19 vaccine for children of this age exceeded the risks of side effects. A day prior to that, vaccine developer companies Pfizer and BioNTech said that their vaccine had demonstrated over 90% efficacy in children aged 5 to 11. In the paper, the firms did, however, note the risk of post-vaccination myocarditis in youngsters.Those above the age of 12 are currently allowed to take the Pfizer vaccine in an emergency, and those aged 16 and up are fully sanctioned. COVID-19 has infected at least 1.8 million children aged 5 to 11 in the US since the outbreak began, with at least 143 children in this age group dying as a result.
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2021
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
us, vaccination, pfizer, vaccine, food and drug administration (fda), covid-19, delta variant of covid-19
us, vaccination, pfizer, vaccine, food and drug administration (fda), covid-19, delta variant of covid-19
US Approves Emergency Use of Pfizer COVID-19 Vaccine for Children 5-11 Years Old
19:45 GMT 29.10.2021 (Updated: 19:46 GMT 29.10.2021) WASHINGTON (Sputnik) - The US Food and Drug Administration (FDA) said on Friday it approved the emergency use of the Pfizer coronavirus vaccine in children ages five to 11 years old.
"Today, the US Food and Drug Administration authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age," the FDA said in a press release.
Last Saturday, FDA released a report in which it indicated that the predicted benefits from the Pfizer COVID-19 vaccine for children of this age exceeded the risks of side effects. A day prior to that, vaccine developer companies Pfizer and BioNTech said that their vaccine
had demonstrated over 90% efficacy in children aged 5 to 11.
In the paper, the firms did, however, note the risk of post-vaccination myocarditis in youngsters.
Those above the age of 12 are
currently allowed to take the Pfizer vaccine in an emergency, and those aged 16 and up are fully sanctioned. COVID-19 has infected at least 1.8 million children aged 5 to 11 in the US since the outbreak began, with at least 143 children in this age group dying as a result.
